Caution For Testicular Cancer Survivors!

Testicular cancer is the most common type of cancer in young men ages 15 to 35. Early detection is critical because testicular cancer typically grows quickly and begins to spread to other parts of the body just a few months after the first symptoms appear. But treated early, it is almost 100 percent curable.

Recent studies stated that long-term testicular cancer survivors who received treatment with cisplatin-based chemotherapy are experiencing more severe side effects such as neurological and Raynaud-like phenomena when compared to men who were not received chemotherapy.

Side effects include: tinnitus, sensory neuropathy, Raynaud-like phenomena (Discoloration of the hands or feet on exposure to cold), and hearing impairment.

Researchers found that at 4 to 21 years after starting the treatment for testicular cancer, men who were received chemotherapy were at considerably higher risk for greater risk of all assessed symptoms when compared to men who were not received chemotherapy.

Men received chemotherapy were suffering from more severe hearing impairment when measured with audiometry than those who were under dose-intensive therapy.

Finally, the study said that the main aim of testicular cancer treatment is to reduce the toxic effects without negotiating the high cure rate.